These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17721076)

  • 1. Targeting the p53 family for cancer therapy: 'big brother' joins the fight.
    Bell HS; Ryan KM
    Cell Cycle; 2007 Aug; 6(16):1995-2000. PubMed ID: 17721076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting mutant p53 for efficient cancer therapy.
    Bykov VJN; Eriksson SE; Bianchi J; Wiman KG
    Nat Rev Cancer; 2018 Feb; 18(2):89-102. PubMed ID: 29242642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting p53 for enhanced radio- and chemo-sensitivity.
    Lu C; El-Deiry WS
    Apoptosis; 2009 Apr; 14(4):597-606. PubMed ID: 19259822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation of mutant p53 by capsaicin, the major constituent of peppers.
    Garufi A; Pistritto G; Cirone M; D'Orazi G
    J Exp Clin Cancer Res; 2016 Sep; 35(1):136. PubMed ID: 27599722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoring p53-dependent tumor suppression.
    Wang W; Rastinejad F; El-Deiry WS
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S55-63. PubMed ID: 14508081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts.
    Wang W; Kim SH; El-Deiry WS
    Proc Natl Acad Sci U S A; 2006 Jul; 103(29):11003-8. PubMed ID: 16835297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor p53 and its gain-of-function mutants in cancer.
    Liu J; Zhang C; Feng Z
    Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):170-9. PubMed ID: 24374774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer.
    Zhang S; Carlsen L; Hernandez Borrero L; Seyhan AA; Tian X; El-Deiry WS
    Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454137
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting mutant p53 for cancer therapy: direct and indirect strategies.
    Hu J; Cao J; Topatana W; Juengpanich S; Li S; Zhang B; Shen J; Cai L; Cai X; Chen M
    J Hematol Oncol; 2021 Sep; 14(1):157. PubMed ID: 34583722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant p53 reactivation by small molecules makes its way to the clinic.
    Bykov VJ; Wiman KG
    FEBS Lett; 2014 Aug; 588(16):2622-7. PubMed ID: 24768524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Awakening the "guardian of genome": reactivation of mutant p53.
    Binayke A; Mishra S; Suman P; Das S; Chander H
    Cancer Chemother Pharmacol; 2019 Jan; 83(1):1-15. PubMed ID: 30324219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of p53 to limit tumor growth.
    Wang W; El-Deiry WS
    Curr Opin Oncol; 2008 Jan; 20(1):90-6. PubMed ID: 18043262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild type p53 function in p53
    Sundar D; Yu Y; Katiyar SP; Putri JF; Dhanjal JK; Wang J; Sari AN; Kolettas E; Kaul SC; Wadhwa R
    J Exp Clin Cancer Res; 2019 Feb; 38(1):103. PubMed ID: 30808373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p53-mediated cytotoxicity of photodynamic therapy of cancer: recent advances.
    Zawacka-Pankau J; Krachulec J; Grulkowski I; Bielawski KP; Selivanova G
    Toxicol Appl Pharmacol; 2008 Nov; 232(3):487-97. PubMed ID: 18721824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-Molecule Prodigiosin Restores p53 Tumor Suppressor Activity in Chemoresistant Colorectal Cancer Stem Cells via c-Jun-Mediated ΔNp73 Inhibition and p73 Activation.
    Prabhu VV; Hong B; Allen JE; Zhang S; Lulla AR; Dicker DT; El-Deiry WS
    Cancer Res; 2016 Apr; 76(7):1989-99. PubMed ID: 26759239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance.
    Stiewe T; Haran TE
    Drug Resist Updat; 2018 May; 38():27-43. PubMed ID: 29857816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances on mutant p53 research].
    Li DH; Zhang LQ; He FC
    Yi Chuan; 2008 Jun; 30(6):697-703. PubMed ID: 18550490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the p53-family in cancer and chemosensitivity: triple threat.
    Chung J; Irwin MS
    Curr Drug Targets; 2010 Jun; 11(6):667-81. PubMed ID: 20298155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 and its downstream proteins as molecular targets of cancer.
    Sun Y
    Mol Carcinog; 2006 Jun; 45(6):409-15. PubMed ID: 16652354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for p53-based cancer therapy.
    Stokłosa T; Gołab J
    Acta Biochim Pol; 2005; 52(2):321-8. PubMed ID: 15990917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.